Clearwater AnalyticsCWAN
CWAN
About: Clearwater Analytics Holdings Inc provides a SaaS solution for automated investment data aggregation, reconciliation, accounting and reporting services to insurers, investment managers, corporations, institutional investors and government entities. It earns revenue from providing access to its SaaS platform to customers, services that support the implementation on the SaaS platform, selling perpetual and term-based software licenses and providing maintenance and support and professional services under contracts with customers. The majority of the revenue is earned in the United States.
Employees: 1,756
0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 8 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
123% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 30
39% more capital invested
Capital invested by funds: $3.65B [Q2] → $5.08B (+$1.43B) [Q3]
33% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 4 (+1) [Q3]
23% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 75
15% more funds holding
Funds holding: 226 [Q2] → 260 (+34) [Q3]
9.02% less ownership
Funds ownership: 134.31% [Q2] → 125.29% (-9.02%) [Q3]
43% less call options, than puts
Call options by funds: $1.77M | Put options by funds: $3.11M
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$22
24%
downside
Avg. target
$32
10%
upside
High target
$40
38%
upside
8 analyst ratings
6 positive
75%
1 neutral
13%
1 negative
13%
Morgan Stanley James Faucette 63% 1-year accuracy 17 / 27 met price target | 17%upside $34 | Overweight Upgraded | 17 Jan 2025 |
DA Davidson Peter Heckmann 72% 1-year accuracy 34 / 47 met price target | 10%upside $32 | Buy Upgraded | 14 Jan 2025 |
RBC Capital Rishi Jaluria 46% 1-year accuracy 36 / 79 met price target | 3%upside $30 | Outperform Maintained | 14 Jan 2025 |
Wells Fargo Michael Turrin 54% 1-year accuracy 47 / 87 met price target | 21%upside $35 | Overweight Maintained | 5 Dec 2024 |
Oppenheimer Brian Schwartz 57% 1-year accuracy 26 / 46 met price target | 38%upside $40 | Outperform Maintained | 3 Dec 2024 |
Financial journalist opinion
Based on 8 articles about CWAN published over the past 30 days
Neutral
CNBC Television
1 week ago
Final Trade: CWAN, MSTR, XLF, PINS
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Neutral
Business Wire
1 week ago
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc. - ENFN
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics Holdings, Inc. (NYSE: CWAN). Under the terms of the proposed transaction, shareholders of Enfusion will receive $5.85 in cash and $5.40 in Clearwater Class A Common Stock for each share of Enfusion that they own. KSF is seeking to determine whether this consi.
Neutral
PRNewsWire
1 week ago
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc.
NEW YORK , Jan. 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Enfusion, Inc. (NYSE: ENFN) and its board of directors concerning the proposed acquisition of the company by Clearwater Analytics (NYSE: CWAN). Stockholders will receive a mix of shares of Clearwater Analytics common stock and cash worth $11.25 for each share of Enfusion stock that they hold.
Positive
TechCrunch
1 week ago
Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics, a company developing accounting, compliance, and risk reporting tools for asset managers, said on Monday it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion.
Positive
Reuters
1 week ago
Clearwater Analytics to acquire Enfusion in $1.5 bln deal
Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday.
Neutral
Business Wire
1 week ago
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
BOISE, Idaho & CHICAGO--(BUSINESS WIRE)--Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate E.
Positive
Zacks Investment Research
2 weeks ago
Clearwater Analytics (CWAN) Upgraded to Strong Buy: What Does It Mean for the Stock?
Clearwater Analytics (CWAN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Positive
Zacks Investment Research
2 weeks ago
Best Momentum Stocks to Buy for January 3rd
SRDX and CWAN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 3, 2024.
Negative
Investors Business Daily
1 month ago
AI Stock Clearwater Analytics Pulls Back To Key Level Following Big Earnings Move
AI stock Clearwater Analytics is looking for support at a key level, which would offer a new buying opportunity. The post AI Stock Clearwater Analytics Pulls Back To Key Level Following Big Earnings Move appeared first on Investor's Business Daily.
Positive
Seeking Alpha
1 month ago
Clearwater Analytics Holdings: Positive On Growth Acceleration
I maintain a buy rating for Clearwater Analytics Holdings with an upgraded price target of $38, driven by robust growth prospects and strong demand. Key growth drivers include successful cross-selling of new products and revenue tailwinds from interest rate reductions, supporting mid-20s% revenue growth in the coming years. High incremental margins from these growth drivers suggest CWAN could exceed its FY24 adj EBITDA guidance, especially with continued Fed rate cuts.
Charts implemented using Lightweight Charts™